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INTRODUCTION
Henoch-Schönlein Purpura (HSP) is a systemic vasculitis 
mediated by IgA and characterized by the clinical triad of 
non-thrombocytopenic palpable purpura, abdominal pain, 
and arthritis. In addition, there may be varying degrees of re-
nal involvement. It is the most frequent vasculitis in children 
and the incidence in adults varies from 3.4 to 14.3 cases per 
million, depending upon the experimental series analyzed.1
We report the onset, course and response to treatment of 
ﬁve adult patients who required hospitalization at our institu-
tion between 2002 and 2006 (all fulﬁlled the 1990 American 
College of Rheumatology (ACR) criteria).2
Case 1: A 24-year-old white male with frequent episodes 
of pharyngitis was admitted for an eight day course of pal-
pable purpuric lesions on his lower limbs, arthritis in both 
ankles, and diffuse abdominal pain. A complete blood count 
with differential analysis, liver function test, coagulation test, 
chemistry panel, and ERS were normal. A urinary sediment 
showed dysmorphic hematuria with 30 to 40 red blood cells/
high power ﬁeld and proteinuria of 2.29 g / 24 hr. A skin bi-
opsy of the lower limbs showed leukocytoclastic vasculitis. 
IgA and C3 deposits were observed upon immunoﬂuorescent 
assay. The renal biopsy indicated mesangial nephropathy due 
to IgA deposition (Figure 1).
The patient began treatment with IV methylprednisolone, 
1 g/day for 3 days, and continued with oral prednisone, 40 
mg/day. During treatment, the patient presented an increase 
in proteinuria (3.12 g/day), the persistence of dysmorphic 
hematuria, and developed hypertension. He was therefore 
treated with IV cyclophosphamide, 1g/m²/month for six 
months, and enalapril, 10 mg/day. Both blood and urine 
laboratory parameters stabilized after the ﬁrst pulse of cy-
clophosphamide.
Case 2: A 68-year-old white male with a clinical back-
ground of cigarette smoking, arterial hypertension, insulin-
dependent diabetes mellitus, and chronic kidney failure 
under hemodialysis treatment was admitted for a four day 
long bought of diarrhea and diffuse abdominal pain, fol-
lowed by the appearance of palpable purpuric lesions on the 
lower limbs two days prior to consultation. The laboratory 
results of the patient on admission showed the following: 
hematocrit 21%; hemoglobin 6.8 mg/dL; leukocyte count 
17,500/mm³ (neutrophils 86%, lymphocytes 8%); platelet 
count 460,000/mm³; ERS 77 mm/hour; glycemia 98 mg/dL; 
serum urea nitrogen 99 mg/dL (normal range 15 – 50 mg/
dL); creatinine 5.3 mg/dL (normal range 0.6 – 1.3 mg/dL); 
and normal liver and coagulation studies. A skin biopsy of 
the lower limb lesions was performed and showed leukocy-
toclastic vasculitis with IgA and C3 deposition. The patient’s 
follow-up was favorable, with spontaneous resolution of 
the cutaneous lesions and disappearance of the abdominal 
symptoms. Therefore, he did not require treatment. 
Case 3: A 77-year-old white male with a clinical history 
of cigarette smoking, myocardial infarction and aortic valve 
replacement (due to severe stenosis) anticoagulated with 
coumarin began experiencing episodes of non-bloody diar-
rhea associated with diffuse abdominal pain 40 days prior to 
Figure 1 - Renal biopsy with mesangial IgA deposition (inmunoﬂuores-
cence, 200X)
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consultation. Later on, palpable purpuric lesions appeared 
on all four limbs and trunk. Laboratory tests showed the 
following: hemoglobin 12.4 mg/dL; leukocyte count 9,900/
mm³ (neutrophils 68%, lymphocytes 23%); platelet count 
120,000/mm³; serum nitrogen urea 120 mg/dL (normal range 
15 – 50 mg/dL); creatinine 2.4 mg/dL (normal range 0.6 – 
1.3 mg/dL); ERS 83 mm/hour; and IgA plasma dosage 514 
mg/dL (normal range 95 – 283 mg/dL). 
A urinary sediment showed dysmorphic hematuria, but 
no evidence of proteinuria. A stool sample showed no inﬂam-
matory reaction, and the stool culture was negative. A biopsy 
of the lower limb skin lesions reported leukocytoclastic 
vasculitis. Due to the risk of suspending anticoagulant treat-
ment, a renal biopsy was not performed. Empirical treatment 
was initiated with IV methylprednisolone, 1 g IV for three 
days, then continued with oral meprednisone at a dose of 60 
mg/day (which was later tapered) and monthly pulses of IV 
cyclophosphamide (a total of six pulses). The patient pre-
sented an improvement in renal function and disappearance 
of hematuria after the ﬁrst pulse of cyclophosphamide.
Case 4: A 68-year-old white male with a clinical history 
of cigarette smoking, had a fever and palpable purpuric le-
sions on all four limbs 15 days prior to admission (Figure 2). 
Later, he presented colicky abdominal pain, predominantly 
in the hypogastrium, and two episodes of melena.
Laboratory results showed the following: ERS 85 mm/
hour, and a urinary sediment presented 30 – 40 red blood 
cells/high power field (90% dysmorphic), protein + +, 
granular, cell and mixed casts, and proteinuria 2.4 g/ 24 hr. 
Test results were negative for antinuclear antibodies, ANCA, 
rheumatoid factor (RF) , cryoglobulins, HBsAg and HCV se-
rology. His serum complement levels (C3-C4) were normal. 
A biopsy of the skin was performed; immunoﬂuoresence 
for IgA, IgG, and C3 were negative. A renal biopsy showed 
mesangial glomerulopathy by IgA deposits.
The patient presented a favorable clinical response as 
well as an improvement in the laboratory parameters with 
oral meprednisone, 80 mg/day. The condition did not recur 
during or after corticosteroid tapering.
Case 5: A 64-year-old white female was admitted with 
palpable purpuric lesions on the lower limbs which appeared 
24 hr prior to consultation. The lesions then extended to the 
upper limbs and trunk, in addition to palmar and plantar 
edema and arthralgias.
The patient had suffered an upper respiratory tract infec-
tion with spontaneous resolution one week prior to admis-
sion. The indices of renal, liver, and coagulation function 
were normal. Immunologic tests showed the following: ANA 
(HEp-2) + 1/40 homogenous pattern, anti-dsDNA (-), ANCA 
(-) and normal serum complement levels. A urinary sediment 
analysis showed the following: protein (4+), leukocytes 10, 
40 dysmorphic red blood cells/high power ﬁeld, fatty oval 
bodies, granular, and white blood cell casts. A biopsy of the 
skin of the right thigh showed leukocytoclastic vasculitis and 
immunoﬂuoresence IgA was positive. A renal biopsy showed 
mesangial nephropathy with IgA deposition. The patient 
developed arterial hypertension that was difﬁcult to control, 
oliguria, and a deterioration of renal function. Therefore, the 
patient started treatment with IV methylprednisone, 3 g (1 
g/day for 3 days), and then meprednisone, 1 mg/kg/day and 
IV cyclophosphamide, 1 g/m² (6 pulses monthly). Clinical 
response, kidney function, and urinary sediment analysis 
were favorable. 
DISCUSSION
HSP is a systemic small vessel vasculitis characterized 
by the deposition of IgA complexes in tissues. It generally 
has a self-limited course, and its main clinical manifestations 
can be seen in skin, joints, the gastrointestinal tract, and 
the kidneys. Less frequently, other organs and/or systems, 
such as the lungs, the central nervous system (CNS) and the 
genito-urinary tract, can be affected.3
Though the etiology of the disease is unknown, multiple 
infectious agents have been suggested to be responsible.4 In 
adults (as opposed to children), renal involvement and the 
possibility of progression to kidney failure are greater. The 
prevalence is greater in males.5
Only two of our patients presented joint involvement, 
which corresponds to data published from other series.6
In addition, four of them had nephropathy (Table 1). Our 
patients with renal involvement presented with dysmorphic 
hematuria and non-nephrotic range proteinuria in three cases. 
Serum creatinine levels were high in two of the patients. 
Kidney involvement usually determines the prognosis;7
although the most frequent histological ﬁnding is mesangial 
proliferation,8 lesions range from minimal change to severe Figure 2 - Palpable purpuric lesions on the lower limbs
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crescenteric glomerulonephritis.9 A signiﬁcant number of 
patients (up to 36%) in some series may suffer permanent 
renal damage.10
The following predictors of a poor renal course in adults 
Table 1 - Clinical manifestations of ﬁve adults with Henoch-
Schönlein Purpura
Clinical manifestations Number of cases
Palpable purpura 5 (100%)
Joint manifestations 2 (40%)
Renal manifestations
Hematuria 4 (80%)
Proteinuria 3 (60%)
Renal insufﬁciency 2 (1 previous) (40%)
Gastrointestinal Manifestations
Bowel angina 4 (80%)
Gastroinstestinal bleeding 1 (20%)
have been proposed: high creatinine levels at onset, protei-
nuria greater than 1 g/day, arterial hypertension, increase of 
proteinuria during follow-up, extracapillary proliferation in 
the renal biopsy, interstitial ﬁbrosis and tubular atrophy.10
Although there are no randomized studies that prove the 
efﬁcacy of one therapy over another (especially for kidney 
involvement), corticosteroids have been used at high doses, 
either orally or in pulses of methylprednisone, and in as-
sociation (or not) with immunosuppressive agents, such as 
cyclophosphamide or azathioprine.11
Because of their poor prognosis, according to studies 
mentioned previously, three patients were treated with pulses 
of corticosteroids and monthly IV cyclophosphamide with 
a favorable clinical response as well as improvements in 
laboratory parameters, with no renal sequelae.
Although HSP is infrequent in adults, renal involvement 
deserves special attention because it darkens the prognosis. 
Thus, these patients should be detected and treated as early 
as possible.
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